Reclassifying Cannabis as a Schedule III Drug Only Exacerbates a Bad Situation
In an op-ed co-authored for the Los Angeles Times, Professor Leo Beletksy and Shanel Lindsay ’07 call for a ”modern regulatory structure that can steward our complex and diverse uses for psychoactive drugs into the 21st century.”